Variable | Univariable analysis | Multivariable analysis | ||
---|---|---|---|---|
HR (95% CI) | p-value | HR (95% CI) | p-value | |
Age | 1.00 (0.99–1.02) | 0.869 |  |  |
Sex (male vs. female) | 1.35 (0.78–2.34) | 0.284 |  |  |
BMI (> 23 kg/m2 vs. ≤ 23 kg/m2) | 0.88 (0.62–1.23) | 0.445 |  |  |
Smoking (yes vs. no) | 1.03 (0.77–1.4) | 0.823 |  |  |
Drinking (yes vs. no) | 0.96 (0.71–1.31) | 0.810 |  |  |
Hypertension (yes vs. no) | 0.92 (0.59–1.44) | 0.717 |  |  |
Diabetes (yes vs. no) | 1.39 (0.88–2.2) | 0.156 |  |  |
HBsAg (positive vs. negative) | 1.16 (0.82–1.66) | 0.399 |  |  |
Cirrhosis (yes vs. no) | 1.29 (0.93–1.8) | 0.129 |  |  |
MVI (yes vs. no) | 1.29 (0.95–1.75) | 0.097 |  |  |
Extrahepatic metastasis (yes vs. no) | 1.36 (1.01–1.84) | 0.046 | 1.27 (0.88–1.83) | 0.198 |
Tumor size (> 6 cm vs. ≤ 6 cm) | 1.7 (1.26–2.31) | 0.001 | 0.86 (0.58–1.28) | 0.465 |
Tumor number (> 3 vs. ≤ 3) | 2.13 (1.57–2.89) |  < 0.001 | 1.69 (1.21–2.37) | 0.002 |
BCLC stage C (yes vs. no) | 1.54 (1.05–2.25) | 0.027 | 1.09 (0.70–1.72) | 0.697 |
Child Paugh class (B vs. A) | 1.47 (1.03–2.12) | 0.036 | 0.94 (0.61–1.45) | 0.770 |
BED (> 60 Gy vs. ≤ 60 Gy) | 0.80 (0.59–1.09) | 0.161 |  |  |
PLT (< 100 × 109/L vs. ≥ 100 × 109/L) | 1.82 (1.19–2.79) | 0.006 | 1.74 (1.11–2.73) | 0.017 |
ALC (> 1.8 × 109/L vs. ≤ 1.8 × 109/L) | 0.58 (0.39–0.88) | 0.010 | 0.78 (0.50–1.20) | 0.260 |
ANC (≥ 2 × 109/L vs. < 2 × 109/L) | 1.54 (0.92–2.59) | 0.101 |  |  |
Hb (< 131 g/L vs. ≥ 131 g/L) | 1.50 (1.11–2.03) | 0.009 | 1.31 (0.92–1.84) | 0.131 |
AST (> 40 U/L vs. ≤ 40 U/L) | 1.26 (0.94–1.71) | 0.126 |  |  |
ALT (> 40 U/L vs. ≤ 40 U/L) | 1.03 (0.76–1.4) | 0.839 |  |  |
ALP (> 150 U/L vs. ≤ 150 U/L) | 1.80 (1.31–2.48) |  < 0.001 | 1.65 (1.15–2.37) | 0.006 |
TBIL (> 21umol/L vs. ≤ 21umol/L) | 1.36 (0.97–1.92) | 0.076 |  |  |
Alb (< 55 g/L vs. ≥ 55 g/L) | 1.43 (1.06–1.93) | 0.021 | 1.06 (0.73–1.56) | 0.746 |
PT (> 13 s vs. ≤ 13 s) | 1.21 (0.89–1.65) | 0.213 |  |  |
AFP (≥ 400 ng/ml vs. < 400 ng/ml) | 1.45 (1.07–1.98) | 0.017 | 1.52 (1.10–2.10) | 0.011 |
Prior TACE (yes vs. no) | 1.04 (0.75–1.43) | 0.817 |  |  |
Prior surgery (yes vs. no) | 0.53 (0.39–0.72) |  < 0.001 | 0.63 (0.43–0.93) | 0.020 |
Prior immunotherapy (yes vs. no) | 1.89 (0.77–4.63) | 0.165 |  |  |
Combined immunotherapy (yes vs. no) | 1.15 (0.65–2.05) | 0.627 |  |  |